Roche (RHHBY.US) has received FDA approval for an innovative therapy to treat acute ischemic stroke in adults.

Roche (RHHBY.US) subsidiary Genentech announced that the USA FDA has approved the launch of the thrombolytic agent TNKase (tenecteplase).

Zhitong FinanceMar 4 08:04 ET

FDA Approves Genentech's TNKase In Acute Ischemic Stroke In Adults

BenzingaMar 3 11:47 ET

Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy

BenzingaMar 3 10:12 ET

Reported Sunday, Roche's Genentech Phase III Study Finds Xolair More Effective And Safer Than Oral Immunotherapy For Food Allergies

BenzingaMar 3 02:22 ET

Roche Gets Positive EU Regulatory Opinion for Columvi

Seeking AlphaFeb 28 13:08 ET

WHO Maintains Public Health Emergency Alert on Mpox

Seeking AlphaFeb 27 11:21 ET

Berenberg Keeps Roche at Hold, Awaits Further Evidence of Pipeline Turnaround

MT NewswiresFeb 27 09:14 ET

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF) and Repligen (RGEN)

TipRanksFeb 24 07:10 ET · Ratings

Swiss Market Index Hits All-Time High -- Market Talk

WSJFeb 24 06:24 ET

Trump Tells Big Pharma to Bring Production Home or Face Tariffs: Bloomberg News

Seeking AlphaFeb 22 09:59 ET

Express News | FDA Says Semaglutide Injection Shortage Is Resolved As Of Feb 21

BenzingaFeb 21 09:22 ET

Pfizer Said to Be Discontinuing Roche-partnered Hemophilia Therapy Beqvez

Seeking AlphaFeb 20 15:15 ET

Bernstein Reaffirms Their Buy Rating on Roche Holding AG (RHHVF)

TipRanksFeb 20 07:07 ET · Ratings

Yemaachi Biotechnology Launches The African Cancer Atlas, in Partnership With Roche

BusinesswireFeb 18 14:03 ET

Roche Holding AG Falls Monday, Underperforms Market

Dow JonesFeb 17 12:17 ET

Roche Elecsys SFlt-1/PlGF Ratio for Preeclampsia Receives FDA 510(k) Clearance, Offering a Fast and Reliable Way to Predict the Risk of Developing Severe Preeclampsia

PR NewswireFeb 13 09:00 ET

Roche's Growth Fueled by Key Drugs, Promising Pipeline -- Market Talk

WSJFeb 13 06:43 ET

Roche Holding Raised to Buy From Neutral by UBS

Dow JonesFeb 13 04:15 ET · Ratings

Roche Holding Target Raised to CHF338 From CHF300 by UBS

Dow JonesFeb 13 04:15 ET · Ratings

FDA Approves Genentech's Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)

BusinesswireFeb 12 11:45 ET